Live Breaking News & Updates on Gerhardt attard

APCCC 2024: Future Changes in the Setting of mHSPC

APCCC 2024: Future Changes in the Setting of mHSPC
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

Georgia , United-states , London , City-of , United-kingdom , Switzerland , Lugano , Ticino , Zachary-klaassen , Gerhardt-attard , University-college-london-hospitals , University-college-london

ESMO 2023: How to Best Integrate Biology

ESMO 2023: How to Best Integrate Biology
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , Toronto , Ontario , Canada , Spain , Madrid , Charles-parker , Gerhardt-attard , University-of-toronto , Twitter

Janssen reaches Akeega approval milestone

Treatment involves the treatment of adults with metastatic castration-resistant prostate cancer - News - PharmaTimes

Janssen-cilag-gmb , Gerhardt-attard , Martin-vogel , University-college-london , Janssen-pharmaceutical-companies-of-johnson , European-commission , Janssen-pharmaceutical-companies , Janssen-cilag-gmbh , Akeega- , Janssen , Pproval ,

Niraparib/Abiraterone Acetate Combo Approved in Europe for BRCA1/2+ mCRPC

The European Commission has granted marketing authorization to the dual action tablet comprised of niraparib and abiraterone acetate to be administered with prednisone or prednisolone in adult patients with BRCA1/2-mutated metastatic castration-resistant prostate cancer in whom chemotherapy is not clinically indicated.

United-kingdom , London , City-of , Gerhardt-attard , Janssen-pharmaceutical-companies-of-johnson , European-commission , University-of-college-london , Drug-administration , College-london , Brief-pain-inventory-short-form , Cancers-symposium , Janssen-pharmaceutical-companies

Johnson & Johnson : Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorization for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations

BEERSE, Belgium, 21 April 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission has granted marketing authorisation for AKEEGA®. | April 21, 2023

Beerse , Region-flamande , Belgium , Italy , Germany , France , Spain , United-kingdom , London , City-of , Japan , Janssen-cilag-gmb

Johnson & Johnson : Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations

News Release

Media Enquiries:

Magda Palhota

Phone: +351 91 2799282

Email: mpalhota@its.jnj.com
. | April 21, 2023

Japan , United-kingdom , Belgium , Beerse , Region-flamande , London , City-of , Janssen-cilag-gmb , Peter-lebowitz , Martin-vogel , Magda-palhota , Gerhardt-attard

ASCO GU 2023: Treatment Combinations for Patients Starting Androgen-Deprivation Therapy: Building on Recent Victories

ASCO GU 2023: Treatment Combinations for Patients Starting Androgen-Deprivation Therapy: Building on Recent Victories
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

Georgia , United-states , United-kingdom , Switzerland , London , City-of , San-francisco , California , American , Marina-parry , Zachary-klaassen , Gerhardt-attard

Veracyte Announces Multiple Decipher Urologic Testing Abstracts to be Presented at the 2023 ASCO Genitourinary (GU) Cancers Symposium

Veracyte, Inc. today announced that six abstracts highlighting new data focused on the company’s Decipher urologic cancer testing offerings will be presented at the 2023 ASCO Genitourinary . | February 1, 2023

California , United-states , United-kingdom , South-san-francisco , Michigan , San-francisco , British , Adam-benjamin-weiner , Himanshu-nagar , Shilpa-gupta , Moritz-reike , Gerhardt-attard

THE PROSTATE CANCER FOUNDATION ANNOUNCES 2022 YOUNG INVESTIGATOR AWARDS TOTALING $7.2 MILLION FOR PROSTATE CANCER RESEARCH

/PRNewswire/ The Prostate Cancer Foundation (PCF) today announced the Class of 2022 Young Investigator Award recipients totaling $7.2 million in funding for.

Dana-farber-cancer-institute , Massachusetts , United-states , New-york , United-kingdom , Munich , Bayern , Germany , Texas , California , Columbia-university , Oregon

New Data Presented at ESMO 2022 Show Veracyte's Decipher Prostate Genomic Classifier May Help Inform Personalized Treatment Decisions in Men with Advanced Prostate Cancer

New Data Presented at ESMO 2022 Show Veracyte's Decipher Prostate Genomic Classifier May Help Inform Personalized Treatment Decisions in Men with Advanced Prostate Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

California , United-states , South-san-francisco , Marc-stapley , Gerhardt-attard , Tracy-morris , Shayla-gorman , Elai-davicioni , Treatment-resistance-research-group , Twitter , Nasdaq , Research-use